Name | Number of supported studies | Average coverage | |
---|---|---|---|
CD4-positive, alpha-beta T cell | 8 studies | 19% ± 2% | |
macrophage | 7 studies | 24% ± 8% | |
dendritic cell | 6 studies | 26% ± 6% | |
CD4-positive, alpha-beta memory T cell | 5 studies | 20% ± 4% | |
naive thymus-derived CD4-positive, alpha-beta T cell | 5 studies | 17% ± 1% | |
epithelial cell | 5 studies | 39% ± 11% | |
ciliated cell | 5 studies | 27% ± 7% | |
endothelial cell | 5 studies | 23% ± 4% | |
T follicular helper cell | 5 studies | 20% ± 3% | |
fibroblast | 4 studies | 23% ± 3% | |
plasma cell | 4 studies | 29% ± 11% | |
basal cell | 4 studies | 36% ± 15% | |
effector memory CD4-positive, alpha-beta T cell | 4 studies | 21% ± 3% | |
natural killer cell | 4 studies | 17% ± 2% | |
CD8-positive, alpha-beta memory T cell | 4 studies | 21% ± 6% | |
T cell | 3 studies | 16% ± 1% | |
naive thymus-derived CD8-positive, alpha-beta T cell | 3 studies | 17% ± 3% | |
GABAergic neuron | 3 studies | 24% ± 4% | |
glutamatergic neuron | 3 studies | 39% ± 9% | |
T-helper 17 cell | 3 studies | 20% ± 3% | |
plasmacytoid dendritic cell | 3 studies | 20% ± 4% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 4 studies | 27% ± 7% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
thymus | 100% | 2625.65 | 653 / 653 | 100% | 37.89 | 605 / 605 |
prostate | 100% | 2225.65 | 245 / 245 | 100% | 21.11 | 501 / 502 |
pancreas | 100% | 2024.15 | 328 / 328 | 99% | 18.58 | 177 / 178 |
lung | 100% | 1980.67 | 577 / 578 | 100% | 19.45 | 1150 / 1155 |
kidney | 100% | 2218.19 | 89 / 89 | 99% | 22.68 | 895 / 901 |
breast | 100% | 1758.14 | 459 / 459 | 99% | 17.66 | 1109 / 1118 |
liver | 100% | 1811.59 | 226 / 226 | 99% | 15.30 | 402 / 406 |
bladder | 100% | 1622.95 | 21 / 21 | 98% | 16.73 | 495 / 504 |
esophagus | 100% | 1665.64 | 1442 / 1445 | 98% | 14.83 | 180 / 183 |
stomach | 100% | 1514.46 | 359 / 359 | 98% | 11.22 | 280 / 286 |
intestine | 99% | 1273.50 | 960 / 966 | 98% | 13.02 | 516 / 527 |
uterus | 100% | 1310.54 | 170 / 170 | 97% | 18.76 | 446 / 459 |
brain | 99% | 1374.69 | 2616 / 2642 | 95% | 10.50 | 672 / 705 |
ovary | 100% | 1985.34 | 180 / 180 | 92% | 9.76 | 396 / 430 |
skin | 100% | 1613.11 | 1803 / 1809 | 89% | 10.75 | 422 / 472 |
adrenal gland | 98% | 893.15 | 254 / 258 | 90% | 13.28 | 206 / 230 |
adipose | 100% | 1714.44 | 1204 / 1204 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 100% | 17.21 | 29 / 29 |
spleen | 100% | 2801.42 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 20.69 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 32.65 | 1 / 1 |
blood vessel | 100% | 1603.65 | 1331 / 1335 | 0% | 0 | 0 / 0 |
muscle | 100% | 1012.01 | 800 / 803 | 0% | 0 | 0 / 0 |
peripheral blood | 93% | 916.80 | 864 / 929 | 0% | 0 | 0 / 0 |
heart | 92% | 714.41 | 794 / 861 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 91% | 15.93 | 73 / 80 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0009435 | Biological process | NAD biosynthetic process |
GO_0019674 | Biological process | NAD metabolic process |
GO_0005829 | Cellular component | cytosol |
GO_0005737 | Cellular component | cytoplasm |
GO_0050262 | Molecular function | ribosylnicotinamide kinase activity |
GO_0061769 | Molecular function | ribosylnicotinate kinase activity |
GO_0005515 | Molecular function | protein binding |
GO_0046872 | Molecular function | metal ion binding |
GO_0005524 | Molecular function | ATP binding |
Gene name | NMRK1 |
Protein name | Nicotinamide riboside kinase 1 (NRK 1) (NmR-K 1) (EC 2.7.1.22) (Nicotinic acid riboside kinase 1) (EC 2.7.1.173) (Ribosylnicotinamide kinase 1) (RNK 1) (Ribosylnicotinic acid kinase 1) Nicotinamide riboside kinase 1 |
Synonyms | C9orf95 NRK1 |
Description | FUNCTION: Catalyzes the phosphorylation of nicotinamide riboside (NR) and nicotinic acid riboside (NaR) to form nicotinamide mononucleotide (NMN) and nicotinic acid mononucleotide (NaMN). The enzyme also phosphorylates the antitumor drugs tiazofurin and 3-deazaguanosine. . |
Accessions | B3KN26 ENST00000361092.9 [Q9NWW6-1] ENST00000376808.8 [Q9NWW6-2] ENST00000494066.1 Q5W125 ENST00000376811.5 Q9NWW6 |